Iterum Therapeutics Plc Profit Margin

Iterum Therapeutics Plc (ITRM) currently reports a profit margin of -6913.08% as of September 2025. That compares with -1166.18% in the prior-year period — down 492.8% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Iterum Therapeutics Plc's profit margin history and peer comparisons.

Iterum Therapeutics Plc's profit margin decreased from -1166.18% to -6913.08% — a 492.8% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iterum Therapeutics Plc's profit margin of -6913.08% is lower than the Healthcare sector average of 14.34%. That is roughly 48292.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Iterum Therapeutics Plc's current -6913.08% should be judged against Healthcare norms (sector average: 14.34%) and against ITRM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6913.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Iterum Therapeutics Plc, and consider following ITRM for alerts when major investors trade the stock.